FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Panel Mixed on GSK Anemia Drug Due to Safety

An FDA advisory committee votes to recommend approval of GlaxoSmithKlines anemia drug daprodustat for use in treating chronic kidney disease in adult ...

Medical Devices

California Court Upholds Preemption for Medtronic

Attorney Michelle Yeary says a California state court granted Medtronic summary judgment on several product liability claims involving a spinal cord s...

latest-news-card-1
Human Drugs

Ashley Retiring as CDER Compliance Director

FDA announces the retirement of CDER Office of Compliance director Don Ashley.

latest-news-card-1
Human Drugs

FDA Looking at Marijuana Scheduling Flexibility: Woodcock

FDA principal deputy commissioner Janet Woodcock says the agency is exploring what flexibility it has in reviewing the science and health benefits of ...

latest-news-card-1
Federal Register

EUA Granted for Abbott Monkeypox Diagnostic

Federal Register notice: FDA announces an Emergency Use Authorization for Abbott Molecular and its Alinity m MPXV monkeypox diagnostic test.

latest-news-card-1
Human Drugs

Guide on C-diff Infection Drug Development

FDA makes available a draft guidance entitled Clostridioides difficile Infection (CDI): Developing Drugs for Treatment, Reduction of Recurrence, and P...

latest-news-card-1
Human Drugs

FDA Advancing Treatments for Children

FDA officials list ways in which the agency is promoting the development of pediatric medicines.

latest-news-card-1
Human Drugs

FDA Questions Y-mAbs Neuroblastoma Treatment Efficacy

FDA raises efficacy questions about a Y-mAbs BLA for I-omburtamab to treat pediatric patients with CNS/leptomeningeal metastases from neuroblastoma.

latest-news-card-1
Medical Devices

Digital Health Regulatory Science Opportunities

The CDRH Digital Health Center of Excellence releases a document highlighting topics of interest for regulatory science research and partnerships.

latest-news-card-1
Human Drugs

GSK Scraps Monoclonal Antibody Development for RA

GSK decides not to seek FDA approval for otilimab, an investigational monoclonal antibody targeting granulocyte-macrophage colony-stimulating factor a...